PPM1J
gene geneOn this page
Also known as FLJ35951MGC19531DKFZp434P1514PP2CzetaPPP2CZ
Summary
PPM1J (protein phosphatase, Mg2+/Mn2+ dependent 1J, HGNC:20785) is a protein-coding gene on chromosome 1p13.2, encoding Protein phosphatase 1J (Q5JR12).
This gene encodes the serine/threonine protein phosphatase. The mouse homolog of this gene apparently belongs to the protein phosphatase 2C family of genes. The exact function of this gene is not yet known.
Source: NCBI Gene 333926 — RefSeq curated summary.
At a glance
- GWAS associations: 16
- Clinical variants (ClinVar): 88 total
- MANE Select transcript:
NM_005167
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20785 |
| Approved symbol | PPM1J |
| Name | protein phosphatase, Mg2+/Mn2+ dependent 1J |
| Location | 1p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35951, MGC19531, DKFZp434P1514, PP2Czeta, PPP2CZ |
| Ensembl gene | ENSG00000155367 |
| Ensembl biotype | protein_coding |
| OMIM | 609957 |
| Entrez | 333926 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000309276, ENST00000464951, ENST00000471106, ENST00000482367, ENST00000486709, ENST00000885786, ENST00000885787, ENST00000959101
RefSeq mRNA: 1 — MANE Select: NM_005167
NM_005167
CCDS: CCDS855
Canonical transcript exons
ENST00000309276 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001909279 | 112709998 | 112710310 |
| ENSE00001924238 | 112714976 | 112715332 |
| ENSE00003469654 | 112712744 | 112713031 |
| ENSE00003532042 | 112713497 | 112713611 |
| ENSE00003695126 | 112710744 | 112710851 |
| ENSE00003695313 | 112710460 | 112710611 |
| ENSE00003695840 | 112711266 | 112711384 |
| ENSE00003696447 | 112711008 | 112711071 |
| ENSE00003697099 | 112712345 | 112712457 |
| ENSE00003701483 | 112711971 | 112712055 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 93.96.
FANTOM5 (CAGE): breadth broad, TPM avg 1.3668 / max 100.4426, expressed in 645 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 13880 | 1.0352 | 580 |
| 13878 | 0.2882 | 80 |
| 13881 | 0.0316 | 9 |
| 13882 | 0.0118 | 3 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 93.96 | gold quality |
| left testis | UBERON:0004533 | 93.64 | gold quality |
| testis | UBERON:0000473 | 92.57 | gold quality |
| quadriceps femoris | UBERON:0001377 | 90.85 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.73 | gold quality |
| gastrocnemius | UBERON:0001388 | 86.07 | gold quality |
| muscle of leg | UBERON:0001383 | 85.97 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 85.75 | gold quality |
| apex of heart | UBERON:0002098 | 84.52 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 83.07 | gold quality |
| cerebellar vermis | UBERON:0004720 | 82.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 81.80 | gold quality |
| cerebellum | UBERON:0002037 | 81.78 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 81.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.57 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.30 | gold quality |
| skin of abdomen | UBERON:0001416 | 80.28 | gold quality |
| muscle tissue | UBERON:0002385 | 80.13 | gold quality |
| zone of skin | UBERON:0000014 | 80.00 | gold quality |
| skin of leg | UBERON:0001511 | 79.82 | gold quality |
| heart left ventricle | UBERON:0002084 | 78.07 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 77.79 | gold quality |
| thymus | UBERON:0002370 | 77.31 | silver quality |
| right frontal lobe | UBERON:0002810 | 77.10 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.98 | gold quality |
| frontal cortex | UBERON:0001870 | 76.86 | gold quality |
| primary visual cortex | UBERON:0002436 | 76.70 | gold quality |
| right atrium auricular region | UBERON:0006631 | 76.28 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 75.85 | gold quality |
| amygdala | UBERON:0001876 | 75.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.28 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP53
miRNA regulators (miRDB)
28 targeting PPM1J, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-3975 | 99.62 | 65.97 | 697 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-4677-3P | 99.49 | 67.91 | 1246 |
| HSA-MIR-7151-5P | 99.37 | 67.82 | 613 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-7974 | 99.24 | 65.48 | 1137 |
| HSA-MIR-3154 | 98.94 | 66.55 | 1455 |
| HSA-MIR-4656 | 98.79 | 66.22 | 1306 |
| HSA-MIR-1537-5P | 98.70 | 68.33 | 999 |
| HSA-MIR-5088-3P | 98.29 | 66.63 | 1310 |
| HSA-MIR-7850-5P | 98.12 | 67.28 | 1111 |
| HSA-MIR-4675 | 97.69 | 64.82 | 774 |
| HSA-MIR-4741 | 97.69 | 64.14 | 883 |
| HSA-MIR-192-3P | 97.52 | 67.66 | 1001 |
| HSA-MIR-3620-5P | 97.42 | 63.95 | 792 |
| HSA-MIR-6501-5P | 97.41 | 68.24 | 712 |
| HSA-MIR-1587 | 96.95 | 64.03 | 932 |
| HSA-MIR-5192 | 96.89 | 63.35 | 879 |
Cross-species orthologs
17 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ppm1na | ENSDARG00000010231 |
| danio_rerio | ppm1nb | ENSDARG00000057032 |
| danio_rerio | ppm1h | ENSDARG00000063684 |
| danio_rerio | ppm1j | ENSDARG00000074690 |
| mus_musculus | Ppm1j | ENSMUSG00000002228 |
| rattus_norvegicus | Ppm1j | ENSRNOG00000012481 |
| drosophila_melanogaster | Pdp | FBGN0029958 |
| drosophila_melanogaster | CG17598 | FBGN0031194 |
| drosophila_melanogaster | CG10376 | FBGN0032702 |
| drosophila_melanogaster | Ppm1 | FBGN0035143 |
| drosophila_melanogaster | CG17746 | FBGN0035425 |
| drosophila_melanogaster | Nil | FBGN0039421 |
| drosophila_melanogaster | alph | FBGN0086361 |
| caenorhabditis_elegans | WBGENE00006460 | |
| caenorhabditis_elegans | WBGENE00016580 | |
| caenorhabditis_elegans | WBGENE00018362 | |
| caenorhabditis_elegans | pdp-1 | WBGENE00022832 |
Paralogs (16): PPM1F (ENSG00000100034), TAB1 (ENSG00000100324), PPM1A (ENSG00000100614), PPM1H (ENSG00000111110), PPM1G (ENSG00000115241), ILKAP (ENSG00000132323), PPM1B (ENSG00000138032), PPM1L (ENSG00000163590), PPM1K (ENSG00000163644), PPM1M (ENSG00000164088), PDP1 (ENSG00000164951), PPM1D (ENSG00000170836), PDP2 (ENSG00000172840), PPM1E (ENSG00000175175), PP2D1 (ENSG00000183977), PPM1N (ENSG00000213889)
Protein
Protein identifiers
Protein phosphatase 1J — Q5JR12 (reviewed: Q5JR12)
Alternative names: Protein phosphatase 2C isoform zeta
All UniProt accessions (3): Q5JR12, S4R3C3, S4R3I3
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with UBE2I/UBC9.
Similarity. Belongs to the PP2C family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5JR12-1 | 1 | yes |
| Q5JR12-2 | 2 |
RefSeq proteins (1): NP_005158* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001932 | PPM-type_phosphatase-like_dom | Domain |
| IPR015655 | PP2C | Family |
| IPR036457 | PPM-type-like_dom_sf | Homologous_superfamily |
Pfam: PF00481
Catalyzed reactions (Rhea), 2 shown:
- O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] + phosphate (RHEA:20629)
- O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] + phosphate (RHEA:47004)
UniProt features (10 total): modified residue 2, splice variant 2, sequence variant 2, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JR12-F1 | 84.86 | 0.72 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 66, 76
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 131 (showing top):
XU_GH1_AUTOCRINE_TARGETS_UP, LFA1_Q6, GCANCTGNY_MYOD_Q6, AREB6_03, MAZ_Q6, AP4_Q6, CAGCTG_AP4_Q5, ATF1_Q6, AACTTT_UNKNOWN, PID_P53_DOWNSTREAM_PATHWAY, VDR_Q3, E2F_Q6_01, AP4_01, TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS
GO Biological Process (1): protein dephosphorylation (GO:0006470)
GO Molecular Function (5): [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase activity (GO:0004741), phosphoprotein phosphatase activity (GO:0004721), protein serine/threonine phosphatase activity (GO:0004722), protein binding (GO:0005515), hydrolase activity (GO:0016787)
GO Cellular Component (1): mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| dephosphorylation | 1 |
| protein modification process | 1 |
| protein serine/threonine phosphatase activity | 1 |
| phosphatase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| phosphoprotein phosphatase activity | 1 |
| binding | 1 |
| catalytic activity | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
314 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PPM1J | UBE2I | P50550 | 561 |
| PPM1J | SUMO1 | P55856 | 510 |
| PPM1J | PPTC7 | Q8NI37 | 503 |
| PPM1J | PPM1A | P35813 | 463 |
| PPM1J | PPM1K | Q8N3J5 | 463 |
| PPM1J | MAPK9 | P45984 | 454 |
| PPM1J | PDP1 | Q9P0J1 | 449 |
| PPM1J | KLHDC7A | Q5VTJ3 | 432 |
| PPM1J | SLCO6A1 | Q86UG4 | 424 |
| PPM1J | RILPL1 | Q5EBL4 | 422 |
| PPM1J | ILKAP | Q9H0C8 | 410 |
| PPM1J | EDEM3 | Q9BZQ6 | 397 |
| PPM1J | PP2D1 | A8MPX8 | 390 |
| PPM1J | SLC25A45 | Q8N413 | 379 |
| PPM1J | PPM1D | O15297 | 376 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PPM1J | LGALS14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPM1J | SMARCD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHN1 | PPM1J | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPM1J | SPG21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPM1H | YWHAQ | psi-mi:“MI:0914”(association) | 0.530 |
| SS18L2 | ARID1A | psi-mi:“MI:0914”(association) | 0.480 |
| RAB10 | psi-mi:“MI:0203”(dephosphorylation reaction) | 0.440 | |
| PPM1J | ADORA2A | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPM1J | F2RL1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPM1J | GPR37 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPM1J | PTAFR | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPM1H | ACACB | psi-mi:“MI:0914”(association) | 0.350 |
| PPM1J | ACTR3 | psi-mi:“MI:0914”(association) | 0.350 |
| TXNDC2 | H2AZ1 | psi-mi:“MI:0914”(association) | 0.350 |
| PPM1J | CDKN2C | psi-mi:“MI:0914”(association) | 0.350 |
| PPM1J | TCP1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| LGALS14 | PPM1J | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLEKHN1 | PPM1J | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPG21 | PPM1J | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMARCD1 | PPM1J | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (27): PPM1J (Affinity Capture-MS), ACTR3 (Affinity Capture-MS), BAX (Affinity Capture-MS), DPYSL3 (Affinity Capture-MS), NUFIP2 (Affinity Capture-MS), PPM1H (Affinity Capture-MS), PPM1M (Affinity Capture-MS), SLTM (Affinity Capture-MS), CCT7 (Proximity Label-MS), CCT2 (Proximity Label-MS), CCT5 (Proximity Label-MS), CCT3 (Proximity Label-MS), TCP1 (Proximity Label-MS), CCT4 (Proximity Label-MS), PPM1J (Reconstituted Complex)
ESM2 similar proteins: D4A1F2, E9Q4Z2, F1MF74, F1QWK4, F1RA39, O00763, O81760, O88484, O94851, P51432, P59679, Q01970, Q05AL2, Q09M05, Q0V7V2, Q10S32, Q12851, Q149T7, Q15750, Q28DF4, Q2QN36, Q4U2V3, Q501F9, Q504M2, Q5JR12, Q5MFV5, Q5PNS9, Q5Z8P0, Q641Y6, Q6F6B3, Q6ING9, Q6ZHC8, Q7XCJ7, Q7XJ53, Q7XUC5, Q7Y138, Q7ZU92, Q8BML1, Q8BU27, Q8CF89
Diamond homologs: Q05AL2, Q149T7, Q28DF4, Q2RBJ6, Q3EAF9, Q3EAZ3, Q3UYC0, Q5JR12, Q5M821, Q641Y6, Q8BU27, Q96MI6, Q9P2J9, Q9ULR3, Q53Q11, Q67UX7, Q8LAY8, Q8RXV3, Q9SLA1, P35182, Q9FIF5, Q9LNW3, Q9SUF4, A5PJZ2, O62830, O75688, P35815, P36993, Q5SGD2, Q8BHN0, O62829
SIGNOR signaling
4 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MAPK10 | down-regulates | PPM1J | phosphorylation |
| MAPK8 | down-regulates | PPM1J | phosphorylation |
| MAPK9 | down-regulates | PPM1J | phosphorylation |
| JNK | down-regulates | PPM1J | phosphorylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
88 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 73 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1965 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:112710607:CGTAC:C | acceptor_gain | 1.0000 |
| 1:112710608:GTAC:G | acceptor_gain | 1.0000 |
| 1:112710609:TAC:T | acceptor_gain | 1.0000 |
| 1:112710609:TACC:T | acceptor_loss | 1.0000 |
| 1:112710610:AC:A | acceptor_gain | 1.0000 |
| 1:112710610:ACC:A | acceptor_loss | 1.0000 |
| 1:112710611:CC:C | acceptor_gain | 1.0000 |
| 1:112710611:CCTG:C | acceptor_loss | 1.0000 |
| 1:112710612:C:CA | acceptor_loss | 1.0000 |
| 1:112710612:C:CC | acceptor_gain | 1.0000 |
| 1:112710613:T:A | acceptor_loss | 1.0000 |
| 1:112710615:G:GC | acceptor_gain | 1.0000 |
| 1:112710738:GCTCA:G | donor_loss | 1.0000 |
| 1:112710739:CTCAC:C | donor_loss | 1.0000 |
| 1:112710740:TCA:T | donor_loss | 1.0000 |
| 1:112710741:CAC:C | donor_loss | 1.0000 |
| 1:112710742:ACCTC:A | donor_loss | 1.0000 |
| 1:112710743:C:CT | donor_loss | 1.0000 |
| 1:112710847:CGAGC:C | acceptor_gain | 1.0000 |
| 1:112710848:GAGC:G | acceptor_gain | 1.0000 |
| 1:112710850:GC:G | acceptor_gain | 1.0000 |
| 1:112710850:GCCT:G | acceptor_loss | 1.0000 |
| 1:112710851:CC:C | acceptor_gain | 1.0000 |
| 1:112710851:CCT:C | acceptor_loss | 1.0000 |
| 1:112710851:CCTG:C | acceptor_loss | 1.0000 |
| 1:112710852:C:CA | acceptor_loss | 1.0000 |
| 1:112710852:C:CC | acceptor_gain | 1.0000 |
| 1:112710852:CT:C | acceptor_loss | 1.0000 |
| 1:112710853:T:A | acceptor_loss | 1.0000 |
| 1:112711180:C:CA | donor_gain | 1.0000 |
AlphaMissense
3238 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:112710539:A:G | W431R | 1.000 |
| 1:112710539:A:T | W431R | 1.000 |
| 1:112710206:G:A | S492F | 0.999 |
| 1:112710212:T:A | D490V | 0.999 |
| 1:112710212:T:G | D490A | 0.999 |
| 1:112710215:T:A | D489V | 0.999 |
| 1:112710215:T:G | D489A | 0.999 |
| 1:112710537:C:A | W431C | 0.999 |
| 1:112710537:C:G | W431C | 0.999 |
| 1:112710544:C:T | G429D | 0.999 |
| 1:112710547:T:A | D428V | 0.999 |
| 1:112710547:T:G | D428A | 0.999 |
| 1:112710820:C:G | R381P | 0.999 |
| 1:112711267:A:G | W349R | 0.999 |
| 1:112711267:A:T | W349R | 0.999 |
| 1:112711287:C:G | R342P | 0.999 |
| 1:112711349:G:C | F321L | 0.999 |
| 1:112711349:G:T | F321L | 0.999 |
| 1:112711351:A:G | F321L | 0.999 |
| 1:112712351:T:A | D279V | 0.999 |
| 1:112712351:T:G | D279A | 0.999 |
| 1:112713576:T:G | D121A | 0.999 |
| 1:112713593:C:A | K115N | 0.999 |
| 1:112713593:C:G | K115N | 0.999 |
| 1:112713602:A:C | N112K | 0.999 |
| 1:112713602:A:T | N112K | 0.999 |
| 1:112710203:A:T | V493D | 0.998 |
| 1:112710206:G:T | S492Y | 0.998 |
| 1:112710213:C:G | D490H | 0.998 |
| 1:112710214:A:C | D489E | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000424483 (1:112716056 T>G), RS1000595945 (1:112711697 T>G), RS1000807781 (1:112717122 A>C), RS1001131509 (1:112715073 G>A), RS1001155217 (1:112717298 G>A,C), RS1001859887 (1:112716681 G>A), RS1001921219 (1:112715473 G>A,C), RS1002039649 (1:112716033 T>C), RS1002313704 (1:112716367 G>C), RS1002318508 (1:112711077 G>A), RS1002525643 (1:112714434 G>A), RS1002531802 (1:112713125 G>A), RS1002537856 (1:112716323 G>A), RS1002991691 (1:112714200 C>T), RS1003881672 (1:112716315 C>A,T)
Disease associations
OMIM: gene MIM:609957 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
16 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007876_66 | Estimated glomerular filtration rate | 4.000000e-16 |
| GCST008058_177 | Estimated glomerular filtration rate | 6.000000e-33 |
| GCST008059_130 | Estimated glomerular filtration rate | 6.000000e-34 |
| GCST008064_31 | Chronic kidney disease | 2.000000e-06 |
| GCST008745_85 | Estimated glomerular filtration rate in non-diabetics | 4.000000e-08 |
| GCST008747_1 | Estimated glomerular filtration rate | 2.000000e-25 |
| GCST008747_61 | Estimated glomerular filtration rate | 9.000000e-18 |
| GCST010696_10 | Cortical thickness (min-P) | 6.000000e-41 |
| GCST010697_23 | Cortical surface area (min-P) | 1.000000e-08 |
| GCST010698_26 | Subcortical volume (min-P) | 2.000000e-08 |
| GCST010699_12 | Brain morphology (min-P) | 2.000000e-10 |
| GCST010700_13 | Cortical thickness (MOSTest) | 8.000000e-13 |
| GCST010701_138 | Cortical surface area (MOSTest) | 9.000000e-10 |
| GCST010702_169 | Subcortical volume (MOSTest) | 2.000000e-17 |
| GCST010703_263 | Brain morphology (MOSTest) | 3.000000e-13 |
| GCST90000025_763 | Appendicular lean mass | 4.000000e-13 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 8 |
| entinostat | increases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, increases expression | 2 |
| Aflatoxin B1 | decreases methylation, increases expression | 2 |
| OTX015 | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| mivebresib | increases expression | 1 |
| methyleugenol | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| potassium perchlorate | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| butyraldehyde | increases expression | 1 |
| pentanal | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Aldehydes | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Estradiol | increases expression | 1 |
| Ethinyl Estradiol | increases expression | 1 |
| Lead | affects expression | 1 |
| Selenium | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TF44 | HAP1 PPM1J (-) 1 | Cancer cell line | Male |
| CVCL_TF45 | HAP1 PPM1J (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.